Simmunome AI
Montreal
About Simmunome AI
Simmunome is an artificial intelligence-based contract research organization. They develop industry-ready computational models of pathogenesis and immunogenesis of various diseases with a particular focus on oncology and the nervous system. Our models are achieved by annotating cellular interactions at an in-depth, comprehensive molecular level to attain physiological accuracy
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $1.5M
- Funding stage: Seed
- Last round: Non-Equity Assistance (Apr 2025)
- Website: simmunome.com
- Phone: 514-518-6292
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Genetics, Health Care
Social Profiles
Canonical: https://fsome.com/organization/simmunome-ai-43038 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.